KURN Kuros Biosciences AG

19.07CHF+3.58%Mkt Cap: 863.47M $P/E: 112.18

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two se…

Key Statistics

Company
Market Cap863.47M USD
Enterprise Value851.85M USD
Revenue (TTM)199.65M USD
Gross Profit147.69M USD
Net Income (TTM)2.91M USD
Revenue/Share4.56 CHF
Last Price19.07 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees213
CountryCH
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)112.18
P/E (Forward)38.76
PEG—
EV/EBITDA55.78
EV/Revenue4.27
P/S4.23
P/B10.67
EPS (TTM)0.17
EPS (Forward)0.48
52W Range
16.4615% of range34.20
52W High34.20 CHF
52W Low16.46 CHF
Profitability
Gross Margin88.60%
Oper. Margin5.61%
EBITDA Margin7.65%
Profit Margin1.75%
ROE3.02%
ROA1.91%
Growth
Revenue Growth45.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-519.29K USD
CapEx (TTM)2.78M USD
FCF Margin-5.75%
FCF Yield-1.33%
Net Debt381.20K USD
Net Debt/EBITDA0.02
Balance Sheet
Debt/Equity0.02
Current Ratio1.87
Quick Ratio1.22
Book Value/Sh1.75 CHF
Cash/Share0.24 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CHF
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 8, 2020
Splits
Last Split1:100
Split DateJun 23, 2016
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)34.29 CHF
Upside (mean)+79.8%
Target Range32.00 CHF – 38.00 CHF
32.00+79.8% to mean38.00
# Analysts3
Ownership
Shares Out.39.67M
Float30.55M
Insiders34.42%
Institutions22.21%
Technical
SMA 5020.10 (-5.1%)
SMA 20022.50 (-15.2%)
Beta0.74
S&P 52W Chg14.58%
Avg Vol (30d)222.57K
Avg Vol (10d)201.35K
Technical Indicators
RSI (14)54.5
MACD-0.2633
MACD Signal-0.5764
MACD Hist.+0.3131
BB Upper19.35 CHF
BB Middle17.82 CHF
BB Lower16.29 CHF
BB Width17.16%
ATR (14)0.9014 CHF
Vol Ratio (20d)1.32x